Early cartographers, without the luxury of an aerial view of their surroundings, did their best to map expanses of land based on expeditions and, of course, on previous maps. Although quite helpful, they and their maps were often less than perfect. Cartographers sketching the layout of the American colonies, for example, might map a lake or a mountain that simply didn't exist. Subsequent maps might then incorporate the make-believe landmark, sometimes even "moving" it several miles from its pre
 |
The same could be said of science and scientists' efforts to map out the "truth." Errors of observation and interpretation inevitably creep in, and corrections must be made. But it's difficult to overcome well-established maps of science drawn by well-established scientists. Investigators, perhaps prone to the all-too-human tendency to see what they want to see, may confirm findings that simply aren't valid.
At an American Association for the Advancement ...
When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.
View this Issue
In this half-day virtual summit, a series of presentations will explore the scientific, regulatory, and operational factors impacting the use of in vitro NAMs in drug discovery.
In this webinar, scientists will discuss innovations that are unlocking new insights into immunity.
In this webinar, Magdalena Pacewicz will highlight how to use AUC to characterize AAVs as part of ensuring regulatory compliance.
Discover how the latest cancer research models and their applications help scientists pursue breakthrough cancer therapy research.
Chief Business Officer Dr. Rob Burgess Shares How Sino Biological Is Empowering Global Biomedical Research Through Precision, Quality, and Innovation on an Exclusive Segment on Fox Business Network airing on February 1, 2026 at 4:30pm EST
Sino Biological, Inc. has announced the accelerated availability and development of critical research tools to support the global scientific community in combating NiV.
Collaboration will bring next generation orchestration and modular automation to scientists worldwide
The ranking places Refeyn among a cohort of high-growth UK technology firms spanning sectors including the life sciences, energy and sustainability, telecommunications, and digital technology.
